Healthcare · Pharmaceutical expenditure
Norway is among the world leaders in pharmaceutical expenditure — 2.50 % GDP of GDP in 2026. This high figure stems not from inefficiency but from costly innovative drugs actively procured for the healthcare system and harsh climatic conditions requiring special logistics for delivering medicines to Arctic regions. The country ranks 3 out of 197 nations.
Data for 2026 · unit: % GDP
Position
#3 / 197
Norway world ranking
Country position on the scale from last to first place for this indicator.
NO
#3
#197#1
Trend
Change over time
Change in indicator over the available period.
1.20
1990
1.80
2000
2.10
2010
2.40
2020
2.50
2026
Values — % GDP
Comparison
Top countries by Pharmaceutical expenditure
Where Norway stands in the world ranking.
1
USUSA
2.65
2
NLNetherlands
2.60
3
NONorway
2.50
4
MCMonaco
2.40
4
NZNew Zealand
2.40
6
DEGermany
2.35
7
JPJapan
2.30
8
FRFrance
2.25
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Pharmaceutical expenditure in Norway — how much?
Based on 2026 data — 2.50 % GDP. This is rank #3 out of 197 countries.
What is Norway's rank by Pharmaceutical expenditure?
Norway ranks #3 out of 197 countries in the world ranking by «Pharmaceutical expenditure».
How has Pharmaceutical expenditure changed in Norway?
Over the available period the indicator changed from 1.20 to 2.50 % GDP.